AstraZeneca, Alveofit collaborate to boost lung diseases treatment in India

As a part of this partnership with Alveofit, AstraZeneca will provide Alveofit IoT enabled handheld spirometers to the clinics and last mile hospitals.

Published On 2022-08-17 04:30 GMT | Update On 2022-08-17 15:19 GMT

...

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

AstraZeneca, Alveofit collaborate to boost lung diseases treatment in India

As a part of this partnership with Alveofit, AstraZeneca will provide Alveofit IoT enabled handheld spirometers to the clinics and last mile hospitals.

Similar News